South Australian Immunogenomics Cancer Institute (SAIGENCI)

SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.

Join our team

About SAiGENCI

Allied partners

Advisory board

Governance

Contact us

Leadership appointments

Professor Melissa Davis

Professor Melissa Davis has been appointed Program Leader, Cancer Systems Biology. She will commence with SAiGENCI in March 2022 on a part-time basis until joining the Institute full-time in January 2023.

Professor Christopher Sweeney

Professor Christopher Sweeney has been appointed Director of SAiGENCI. Professor Sweeney is already actively engaged in driving SAiGENCI’s strategic direction and will visit Adelaide regularly during 2022 as Director Designate. He is expected to take up the position full time in November 2022.

Professor Jose Polo

Professor Jose Polo has been appointed Epigenetics Program Leader in SAiGENCI to build the epigenetics capacity within the Institute. Professor Polo will establish the Adelaide Centre for Epigenetics (ACE) in the Faculty of Health and Medical Sciences.

Scientific appointments

Professor Lisa Butler

Professor Lisa Butler has been appointed Lead SAiGENCI Associate in SAHMRI, and Prostate Cancer Theme Lead in the Hormone Dependent Cancers Program. She will also lead SAiGENCI’s Graduate Program for HDR and Honours students.